The characteristics and risk of obesity central and concomitant impaired fasting glucose: Findings from a cross-sectional study

被引:0
作者
Liberty, Iche Andriyani [1 ]
Septadina, Indri Seta [2 ]
Novita, Emma [2 ]
Amalia, Resi [3 ]
Ananingsih, Esti Sri [4 ]
Hasyim, Hamzah [5 ]
Hanifah, Laily [6 ]
机构
[1] Univ Sriwijaya, Fac Med, Dept Publ Hlth & Community Med, Palembang, Indonesia
[2] Univ Sriwijaya, Fac Med, Dept Anat, Palembang, Indonesia
[3] Univ Muhammadiyah, Fac Med, Palembang, Indonesia
[4] Hlth Minist Polytech, Palembang, Indonesia
[5] Univ Sriwijaya, Fac Publ Hlth, Palembang, Indonesia
[6] Univ Pembangunan Nas Vet Jakarta, Jakarta, Indonesia
关键词
INSULIN-RESISTANCE; METABOLIC ABNORMALITIES; CARDIOVASCULAR-DISEASE; EPIDEMIOLOGY; ASSOCIATION; BEVERAGES; CHILDREN; SUGAR;
D O I
10.1371/journal.pone.0305604
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Obesity is associated with concomitant chronic conditions. An early metabolic consequence of obesity is disruption of glucose and insulin homeostasis. One of the consequences is impaired fasting glucose (IFG). Visceral fat is metabolically more harmful than subcutaneous fat, but few information is available regarding the association between the risk of abnormal glucose in increased waist circumference. Methods This study is based on a cross sectional of 1,381 population-based from Palembang, Indonesia. The eligibility requirements subject were to be older than 18 and consent to taking fasting glucose and lipid profile tests as well as physical exams measuring their body weight, height, blood pressure, abdominal circumference, and waist circumference. Results The number of subjects consisting of 798 noncentral obesity with normoglycemia, 376 central obesity with normoglycemia, and 207 central obesity with concomitant IFG. The prevalence central obesity with concomitant IFG was 35.51%. In subjects with central obesity, there were significant differences in proportions based on sex, age, marital status, education, and occupation. In multivariate analysis show that the risk factors that contribute to having a significant association with central obesity with concomitant IFG are sex (female), age (>40 years), blood pressure (hypertension), and HDL-C <50 mg/dL (p<0.001). The analysis also founded that there was a significant difference in the dietary pattern of sweet foods (p = 0.018), sweet drinks (p = 0.002), soft drinks (p = 0.001) and smoking habit (p<0.001) between subjects with obesity central and concomitant IFG compared to subjects with noncentral obesity. The majority of subjects with obesity central and concomitant IFG had consuming these risky foods >6 times/week. Conclusion The prevalence of central obesity with IFG is quite high. There are significant differences in the characteristics, lipid profile, blood pressure, dietary pattern, and smoking habit of central obesity with concomitant IFG was confirmed in this population-based observational study.
引用
收藏
页数:14
相关论文
共 46 条
[1]   Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes [J].
Ahn, Nayeon ;
Baumeister, Sebastian E. ;
Amann, Ute ;
Rathmann, Wolfgang ;
Peters, Annette ;
Huth, Cornelia ;
Thorand, Barbara ;
Meisinger, Christa .
SCIENTIFIC REPORTS, 2019, 9 (1)
[2]   Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance [J].
Al-Mansoori, Layla ;
Al-Jaber, Hend ;
Prince, Mohammad Shoaib ;
Elrayess, Mohamed A. .
INFLAMMATION, 2022, 45 (01) :31-44
[3]  
Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc14-S081, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc11-S062, 10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc12-s011]
[4]  
[Anonymous], 2011, OV OB
[5]   Analysis of Modifiable, Non-Modifiable , and Physiological Risk Factors of Non-Communicable Diseases in Indonesia: Evidence from the 2018 Indonesian Basic Health Research [J].
Arifin, Hidayat ;
Chou, Kuei-Ru ;
Ibrahim, Kusman ;
Fitri, Siti Ulfah Rifa'atul ;
Pradipta, Rifky Octavia ;
Rias, Yohanes Andy ;
Sitorus, Nikson ;
Wiratama, Bayu Satria ;
Setiawan, Agus ;
Setyowati, Setyowati ;
Kuswanto, Heri ;
Mediarti, Devi ;
Rosnani, Rosnani ;
Sulistini, Rumentalia ;
Pahria, Tuti .
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2022, 15 :2203-2221
[6]   Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents [J].
Cali, Anna M. G. ;
Bonadonna, Riccardo C. ;
Trombetta, Maddalena ;
Weiss, Ram ;
Caprio, Sonia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) :1767-1773
[7]   Etiology of Insulin Resistance in Youth with Type 2 Diabetes [J].
Cree-Green, Melanie ;
Triolo, Taylor M. ;
Nadeau, Kristen J. .
CURRENT DIABETES REPORTS, 2013, 13 (01) :81-88
[8]   Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [J].
Davies, Melanie J. ;
Aroda, Vanita R. ;
Collins, Billy S. ;
Gabbay, Robert A. ;
Green, Jennifer ;
Maruthur, Nisa M. ;
Rosas, Sylvia E. ;
Del Prato, Stefano ;
Mathieu, Chantal ;
Mingrone, Geltrude ;
Rossing, Peter ;
Tankova, Tsvetalina ;
Tsapas, Apostolos ;
Buse, John B. .
DIABETES CARE, 2022, 45 (11) :2753-2786
[9]   Microvascular Dysfunction: A Potential Mechanism in the Pathogenesis of Obesity-associated Insulin Resistance and Hypertension [J].
De Boer, Michiel P. ;
Meijer, Rick I. ;
Wijnstok, Nienke J. ;
Jonk, Amy M. ;
Houben, Alphons J. ;
Stehouwer, Coen D. ;
Smulders, Yvo M. ;
Eringa, Etto C. ;
Serne, Erik H. .
MICROCIRCULATION, 2012, 19 (01) :5-18
[10]   The Role of Estrogen in Insulin Resistance A Review of Clinical and Preclinical Data [J].
De Paoli, Monica ;
Zakharia, Alexander ;
Werstuck, Geoff H. .
AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (09) :1490-1498